Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Taiko Pharmaceutical Co., Ltd. ( (JP:4574) ).
Taiko Pharmaceutical Co., Ltd. has revised its full-year consolidated earnings forecast for the fiscal year ending December 31, 2025. The company expects operating and ordinary profits to exceed previous forecasts due to lower production costs, reduced selling, general and administrative expenses, and favorable foreign exchange rates, while net sales remain consistent with initial projections.
More about Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of medical products. The company is known for its health-related products and has a market focus on pharmaceuticals and healthcare solutions.
Average Trading Volume: 214,415
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen13.82B
Learn more about 4574 stock on TipRanks’ Stock Analysis page.